PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 151 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 128 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 128 | -3.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|